The microbiota-harboring human gut is an exquisitely active ecosystem that has evolved in a constant symbiosis with the human host. It produces numerous compounds depending on its metabolic capacity and substrates availability. Diet is the major source of the substrates that are metabolized to end-products, further serving as signal molecules in the microbiota-host cross-talk. Among these signal molecules, branched-chain amino acids (BCAAs) has gained significant scientific attention. BCAAs are abundant in animal-based dietary sources; they are both produced and degraded by gut microbiota and the host circulating levels are associated with the risk of type 2 diabetes. This review aims to summarize the current knowledge on the complex relationship between gut microbiota and its functional capacity to handle BCAAs as well as the host BCAA metabolism in insulin resistance development. Targeting gut microbiota BCAA metabolism with a dietary modulation could represent a promising approach in the prevention and treatment of insulin resistance related states, such as obesity and diabetes.

Department of Internal Medicine Kralovske Vinohrady University Hospital and 3rd Faculty of Medicine Charles University 10000 Prague Czech Republic

Institute for Clinical and Experimental Medicine 14021 Prague Czech Republic

Zobrazit více v PubMed

Noce A., Marrone G., Di Daniele F., Ottaviani E., Wilson Jones G., Bernini R., Romani A., Rovella V. Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases. Nutrients. 2019;11:1073. doi: 10.3390/nu11051073. PubMed DOI PMC

Cabello-Olmo M., Arana M., Urtasun R., Encio I.J., Barajas M. Role of Postbiotics in Diabetes Mellitus: Current Knowledge and Future Perspectives. Foods. 2021;10:1590. doi: 10.3390/foods10071590. PubMed DOI PMC

Guilloteau P., Martin L., Eeckhaut V., Ducatelle R., Zabielski R., Van Immerseel F. From the gut to the peripheral tissues: The multiple effects of butyrate. Nutr. Res. Rev. 2010;23:366–384. doi: 10.1017/S0954422410000247. PubMed DOI

Cresci G.A., Glueck B., McMullen M.R., Xin W., Allende D., Nagy L.E. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. J. Gastroenterol. Hepatol. 2017;32:1587–1597. doi: 10.1111/jgh.13731. PubMed DOI PMC

Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., de Roos P., Liu H., Cross J.R., Pfeffer K., Coffer P.J., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451–455. doi: 10.1038/nature12726. PubMed DOI PMC

Li R., Mao Z., Ye X., Zuo T. Human Gut Microbiome and Liver Diseases: From Correlation to Causation. Microorganisms. 2021;9:1017. doi: 10.3390/microorganisms9051017. PubMed DOI PMC

Schattenberg J.M., Galle P.R. Animal models of non-alcoholic steatohepatitis: Of mice and man. Dig. Dis. 2010;28:247–254. doi: 10.1159/000282097. PubMed DOI

Rao R.K. Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer. Methods Mol. Biol. 2008;447:171–183. doi: 10.1007/978-1-59745-242-7_13. PubMed DOI

Newgard C.B., An J., Bain J.R., Muehlbauer M.J., Stevens R.D., Lien L.F., Haqq A.M., Shah S.H., Arlotto M., Slentz C.A., et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311–326. doi: 10.1016/j.cmet.2009.02.002. PubMed DOI PMC

Katagiri R., Goto A., Nakagawa T., Nishiumi S., Kobayashi T., Hidaka A., Budhathoki S., Yamaji T., Sawada N., Shimazu T., et al. Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort. Gastroenterology. 2018;155:1474–1482.e1. doi: 10.1053/j.gastro.2018.07.033. PubMed DOI

Tobias D.K., Hazra A., Lawler P.R., Chandler P.D., Chasman D.I., Buring J.E., Lee I.M., Cheng S., Manson J.E., Mora S. Circulating branched-chain amino acids and long-term risk of obesity-related cancers in women. Sci. Rep. 2020;10:16534. doi: 10.1038/s41598-020-73499-x. PubMed DOI PMC

Gojda J., Strakova R., Plihalova A., Tuma P., Potockova J., Polak J., Andel M. Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids. Ann. Nutr. Metab. 2017;70:293–302. doi: 10.1159/000475604. PubMed DOI

Wahren J., Felig P., Hagenfeldt L. Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus. J. Clin. Investig. 1976;57:987–999. doi: 10.1172/JCI108375. PubMed DOI PMC

Vellai T. How the amino acid leucine activates the key cell-growth regulator mTOR. Nature. 2021;596:192–194. doi: 10.1038/d41586-021-01943-7. PubMed DOI

Pedroso J.A., Zampieri T.T., Donato J., Jr. Reviewing the Effects of L-Leucine Supplementation in the Regulation of Food Intake, Energy Balance, and Glucose Homeostasis. Nutrients. 2015;7:3914–3937. doi: 10.3390/nu7053914. PubMed DOI PMC

Holecek M. Branched-chain amino acids in health and disease: Metabolism, alterations in blood plasma, and as supplements. Nutr. Metab. 2018;15:33. doi: 10.1186/s12986-018-0271-1. PubMed DOI PMC

Cole J.T. Metabolism of BCAAs. In: Rajendram R., Preedy V.R., Patel V.B., editors. Branched Chain Amino Acids in Clinical Nutrition. Volume 1. Humana Press; Totowa, NJ, USA: 2015. pp. 13–24.

Tremblay F., Krebs M., Dombrowski L., Brehm A., Bernroider E., Roth E., Nowotny P., Waldhausl W., Marette A., Roden M. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes. 2005;54:2674–2684. doi: 10.2337/diabetes.54.9.2674. PubMed DOI

Nair K.S., Woolf P.D., Welle S.L., Matthews D.E. Leucine, glucose, and energy metabolism after 3 days of fasting in healthy human subjects. Am. J. Clin. Nutr. 1987;46:557–562. doi: 10.1093/ajcn/46.4.557. PubMed DOI

Kamaura M., Nishijima K., Takahashi M., Ando T., Mizushima S., Tochikubo O. Lifestyle modification in metabolic syndrome and associated changes in plasma amino acid profiles. Circ. J. 2010;74:2434–2440. doi: 10.1253/circj.CJ-10-0150. PubMed DOI

Wurtz P., Makinen V.P., Soininen P., Kangas A.J., Tukiainen T., Kettunen J., Savolainen M.J., Tammelin T., Viikari J.S., Ronnemaa T., et al. Metabolic signatures of insulin resistance in 7098 young adults. Diabetes. 2012;61:1372–1380. doi: 10.2337/db11-1355. PubMed DOI PMC

Wang T.J., Larson M.G., Vasan R.S., Cheng S., Rhee E.P., McCabe E., Lewis G.D., Fox C.S., Jacques P.F., Fernandez C., et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 2011;17:448–453. doi: 10.1038/nm.2307. PubMed DOI PMC

Lips M.A., Van Klinken J.B., van Harmelen V., Dharuri H.K., AC’t Hoen P.A., Laros J.F., van Ommen G.J., Janssen I.M., Van Ramshorst B., Van Wagensveld B.A., et al. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes. Diabetes Care. 2014;37:3150–3156. doi: 10.2337/dc14-0195. PubMed DOI

Yin Q., Brameld J.M., Parr T., Murton A.J. Leucine and mTORc1 act independently to regulate 2-deoxyglucose uptake in L6 myotubes. Amino Acids. 2020;52:477–486. doi: 10.1007/s00726-020-02829-0. PubMed DOI

Lynch C.J., Adams S.H. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 2014;10:723–736. doi: 10.1038/nrendo.2014.171. PubMed DOI PMC

Biswas D., Duffley L., Pulinilkunnil T. Role of branched-chain amino acid-catabolizing enzymes in intertissue signaling, metabolic remodeling, and energy homeostasis. FASEB J. 2019;33:8711–8731. doi: 10.1096/fj.201802842RR. PubMed DOI

Newgard C.B. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012;15:606–614. doi: 10.1016/j.cmet.2012.01.024. PubMed DOI PMC

Wang T., Yao W., He Q., Shao Y., Zheng R., Huang F. L-leucine stimulates glutamate dehydrogenase activity and glutamate synthesis by regulating mTORC1/SIRT4 pathway in pig liver. Anim. Nutr. 2018;4:329–337. doi: 10.1016/j.aninu.2017.12.002. PubMed DOI PMC

Binder E., Bermudez-Silva F.J., Andre C., Elie M., Romero-Zerbo S.Y., Leste-Lasserre T., Belluomo I., Duchampt A., Clark S., Aubert A., et al. Leucine supplementation protects from insulin resistance by regulating adiposity levels. PLoS ONE. 2013;8:e74705. doi: 10.1371/journal.pone.0074705. PubMed DOI PMC

Guo K., Yu Y.H., Hou J., Zhang Y. Chronic leucine supplementation improves glycemic control in etiologically distinct mouse models of obesity and diabetes mellitus. Nutr. Metab. 2010;7:57. doi: 10.1186/1743-7075-7-57. PubMed DOI PMC

Hey P., Gow P., Testro A.G., Apostolov R., Chapman B., Sinclair M. Nutraceuticals for the treatment of sarcopenia in chronic liver disease. Clin. Nutr. ESPEN. 2021;41:13–22. doi: 10.1016/j.clnesp.2020.11.015. PubMed DOI

Leenders M., van Loon L.J. Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes. Nutr. Rev. 2011;69:675–689. doi: 10.1111/j.1753-4887.2011.00443.x. PubMed DOI

Maykish A., Sikalidis A.K. Utilization of Hydroxyl-Methyl Butyrate, Leucine, Glutamine and Arginine Supplementation in Nutritional Management of Sarcopenia-Implications and Clinical Considerations for Type 2 Diabetes Mellitus Risk Modulation. J. Pers. Med. 2020;10:19. doi: 10.3390/jpm10010019. PubMed DOI PMC

Sikalidis A.K., Maykish A. The Gut Microbiome and Type 2 Diabetes Mellitus: Discussing a Complex Relationship. Biomedicines. 2020;8:8. doi: 10.3390/biomedicines8010008. PubMed DOI PMC

Soares J.D.P., Howell S.L., Teixeira F.J., Pimentel G.D. Dietary Amino Acids and Immunonutrition Supplementation in Cancer-Induced Skeletal Muscle Mass Depletion: A Mini-Review. Curr. Pharm. Des. 2020;26:970–978. doi: 10.2174/1381612826666200218100420. PubMed DOI

Boulet M.M., Chevrier G., Grenier-Larouche T., Pelletier M., Nadeau M., Scarpa J., Prehn C., Marette A., Adamski J., Tchernof A. Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk. Am. J. Physiol. Endocrinol. Metab. 2015;309:E736–E746. doi: 10.1152/ajpendo.00231.2015. PubMed DOI

Lu J., Xie G., Jia W., Jia W. Insulin resistance and the metabolism of branched-chain amino acids. Front. Med. 2013;7:53–59. doi: 10.1007/s11684-013-0255-5. PubMed DOI

Green C.R., Wallace M., Divakaruni A.S., Phillips S.A., Murphy A.N., Ciaraldi T.P., Metallo C.M. Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis. Nat. Chem. Biol. 2016;12:15–21. doi: 10.1038/nchembio.1961. PubMed DOI PMC

Crown S.B., Marze N., Antoniewicz M.R. Catabolism of Branched Chain Amino Acids Contributes Significantly to Synthesis of Odd-Chain and Even-Chain Fatty Acids in 3T3-L1 Adipocytes. PLoS ONE. 2015;10:e0145850. doi: 10.1371/journal.pone.0145850. PubMed DOI PMC

Herman M.A., She P., Peroni O.D., Lynch C.J., Kahn B.B. Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J. Biol. Chem. 2010;285:11348–11356. doi: 10.1074/jbc.M109.075184. PubMed DOI PMC

Matthews D.E. Observations of branched-chain amino acid administration in humans. J. Nutr. 2005;135:1580S–1584S. doi: 10.1093/jn/135.6.1580S. PubMed DOI PMC

Gojda J., Waldauf P., Hruskova N., Blahutova B., Krajcova A., Urban T., Tuma P., Rasova K., Duska F. Lactate production without hypoxia in skeletal muscle during electrical cycling: Crossover study of femoral venous-arterial differences in healthy volunteers. PLoS ONE. 2019;14:e0200228. doi: 10.1371/journal.pone.0200228. PubMed DOI PMC

Everman S., Meyer C., Tran L., Hoffman N., Carroll C.C., Dedmon W.L., Katsanos C.S. Insulin does not stimulate muscle protein synthesis during increased plasma branched-chain amino acids alone but still decreases whole body proteolysis in humans. Am. J. Physiol. Endocrinol. Metab. 2016;311:E671–E677. doi: 10.1152/ajpendo.00120.2016. PubMed DOI PMC

Calbet J.A., MacLean D.A. Plasma glucagon and insulin responses depend on the rate of appearance of amino acids after ingestion of different protein solutions in humans. J. Nutr. 2002;132:2174–2182. doi: 10.1093/jn/132.8.2174. PubMed DOI

Nilsson M., Stenberg M., Frid A.H., Holst J.J., Bjorck I.M. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: The role of plasma amino acids and incretins. Am. J. Clin. Nutr. 2004;80:1246–1253. doi: 10.1093/ajcn/80.5.1246. PubMed DOI

Pedersen H.K., Gudmundsdottir V., Nielsen H.B., Hyotylainen T., Nielsen T., Jensen B.A., Forslund K., Hildebrand F., Prifti E., Falony G., et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535:376–381. doi: 10.1038/nature18646. PubMed DOI

Liu R., Hong J., Xu X., Feng Q., Zhang D., Gu Y., Shi J., Zhao S., Liu W., Wang X., et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat. Med. 2017;23:859–868. doi: 10.1038/nm.4358. PubMed DOI

Zeng S.L., Li S.Z., Xiao P.T., Cai Y.Y., Chu C., Chen B.Z., Li P., Li J., Liu E.H. Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism. Sci. Adv. 2020;6:eaax6208. doi: 10.1126/sciadv.aax6208. PubMed DOI PMC

Blachier F., Mariotti F., Huneau J.F., Tome D. Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids. 2007;33:547–562. doi: 10.1007/s00726-006-0477-9. PubMed DOI

Davila A.M., Blachier F., Gotteland M., Andriamihaja M., Benetti P.H., Sanz Y., Tome D. Intestinal luminal nitrogen metabolism: Role of the gut microbiota and consequences for the host. Pharmacol. Res. 2013;68:95–107. doi: 10.1016/j.phrs.2012.11.005. PubMed DOI

Reitzer L. Biosynthesis of Glutamate, Aspartate, Asparagine, L-Alanine, and D-Alanine. EcoSal Plus. 2004;1 doi: 10.1128/ecosalplus.3.6.1.3. PubMed DOI

Torrallardona D., Harris C.I., Coates M.E., Fuller M.F. Microbial amino acid synthesis and utilization in rats: Incorporation of 15N from 15NH4Cl into lysine in the tissues of germ-free and conventional rats. Br. J. Nutr. 1996;76:689–700. doi: 10.1079/BJN19960076. PubMed DOI

Metges C.C., El-Khoury A.E., Henneman L., Petzke K.J., Grant I., Bedri S., Pereira P.P., Ajami A.M., Fuller M.F., Young V.R. Availability of intestinal microbial lysine for whole body lysine homeostasis in human subjects. Am. J. Physiol. 1999;277:E597–E607. doi: 10.1152/ajpendo.1999.277.4.E597. PubMed DOI

Metges C.C., Petzke K.J., Hennig U. Gas chromatography/combustion/isotope ratio mass spectrometric comparison of N-acetyl- and N-pivaloyl amino acid esters to measure 15N isotopic abundances in physiological samples: A pilot study on amino acid synthesis in the upper gastro-intestinal tract of minipigs. J. Mass Spectrom. 1996;31:367–376. doi: 10.1002/(SICI)1096-9888(199604)31:43.0.CO;2-V. PubMed DOI

Millward D.J., Forrester T., Ah-Sing E., Yeboah N., Gibson N., Badaloo A., Boyne M., Reade M., Persaud C., Jackson A. The transfer of 15N from urea to lysine in the human infant. Br. J. Nutr. 2000;83:505–512. doi: 10.1017/S0007114500000647. PubMed DOI

Neis E.P., Dejong C.H., Rensen S.S. The role of microbial amino acid metabolism in host metabolism. Nutrients. 2015;7:2930–2946. doi: 10.3390/nu7042930. PubMed DOI PMC

Metges C.C. Contribution of microbial amino acids to amino acid homeostasis of the host. J. Nutr. 2000;130:1857S–1864S. doi: 10.1093/jn/130.7.1857S. PubMed DOI

Sridharan G.V., Choi K., Klemashevich C., Wu C., Prabakaran D., Pan L.B., Steinmeyer S., Mueller C., Yousofshahi M., Alaniz R.C., et al. Prediction and quantification of bioactive microbiota metabolites in the mouse gut. Nat. Commun. 2014;5:5492. doi: 10.1038/ncomms6492. PubMed DOI

Smith E.A., Macfarlane G.T. Enumeration of human colonic bacteria producing phenolic and indolic compounds: Effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J. Appl. Bacteriol. 1996;81:288–302. doi: 10.1111/j.1365-2672.1996.tb04331.x. PubMed DOI

Dai Z.L., Wu G., Zhu W.Y. Amino acid metabolism in intestinal bacteria: Links between gut ecology and host health. Front. Biosci. 2011;16:1768–1786. doi: 10.2741/3820. PubMed DOI

Allison C., Macfarlane G.T. Influence of pH, nutrient availability, and growth rate on amine production by Bacteroides fragilis and Clostridium perfringens. Appl. Environ. Microbiol. 1989;55:2894–2898. doi: 10.1128/aem.55.11.2894-2898.1989. PubMed DOI PMC

Davila A.M., Blachier F., Gotteland M., Andriamihaja M., Benetti P.H., Sanz Y., Tome D. Re-print of “Intestinal luminal nitrogen metabolism: Role of the gut microbiota and consequences for the host”. Pharmacol. Res. 2013;69:114–126. doi: 10.1016/j.phrs.2013.01.003. PubMed DOI

Aguirre M., Eck A., Koenen M.E., Savelkoul P.H., Budding A.E., Venema K. Diet drives quick changes in the metabolic activity and composition of human gut microbiota in a validated in vitro gut model. Res. Microbiol. 2016;167:114–125. doi: 10.1016/j.resmic.2015.09.006. PubMed DOI

Kaiser J.C., Heinrichs D.E. Branching Out: Alterations in Bacterial Physiology and Virulence Due to Branched-Chain Amino Acid Deprivation. mBio. 2018;9:e01188-18. doi: 10.1128/mBio.01188-18. PubMed DOI PMC

Zhang Y.M., Rock C.O. Membrane lipid homeostasis in bacteria. Nat. Rev. Microbiol. 2008;6:222–233. doi: 10.1038/nrmicro1839. PubMed DOI

Scully S.M., Orlygsson J. Branched-chain amino acid catabolism of Thermoanaerobacter pseudoethanolicus reveals potential route to branched-chain alcohol formation. Extremophiles. 2020;24:121–133. doi: 10.1007/s00792-019-01140-5. PubMed DOI

Sun Y., Meng Q., Zhang Y., Gao H. Derepression of bkd by the FadR loss dictates elevated production of BCFAs and isoleucine starvation. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2020;1865:158577. doi: 10.1016/j.bbalip.2019.158577. PubMed DOI

David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–563. doi: 10.1038/nature12820. PubMed DOI PMC

Shortt C., Hasselwander O., Meynier A., Nauta A., Fernandez E.N., Putz P., Rowland I., Swann J., Turk J., Vermeiren J., et al. Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients. Eur. J. Nutr. 2018;57:25–49. doi: 10.1007/s00394-017-1546-4. PubMed DOI PMC

Ottosson F., Brunkwall L., Ericson U., Nilsson P.M., Almgren P., Fernandez C., Melander O., Orho-Melander M. Connection Between BMI-Related Plasma Metabolite Profile and Gut Microbiota. J. Clin. Endocrinol. Metab. 2018;103:1491–1501. doi: 10.1210/jc.2017-02114. PubMed DOI

Org E., Blum Y., Kasela S., Mehrabian M., Kuusisto J., Kangas A.J., Soininen P., Wang Z., Ala-Korpela M., Hazen S.L., et al. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol. 2017;18:70. doi: 10.1186/s13059-017-1194-2. PubMed DOI PMC

Wang F., Wan Y., Yin K., Wei Y., Wang B., Yu X., Ni Y., Zheng J., Huang T., Song M., et al. Lower Circulating Branched-Chain Amino Acid Concentrations Among Vegetarians are Associated with Changes in Gut Microbial Composition and Function. Mol. Nutr. Food Res. 2019;63:e1900612. doi: 10.1002/mnfr.201900612. PubMed DOI

Mesnage R., Grundler F., Schwiertz A., Le Maho Y., Wilhelmi de Toledo F. Changes in human gut microbiota composition are linked to the energy metabolic switch during 10 d of Buchinger fasting. J. Nutr. Sci. 2019;8:e36. doi: 10.1017/jns.2019.33. PubMed DOI PMC

Zhang L., Yue Y., Shi M., Tian M., Ji J., Liao X., Hu X., Chen F. Dietary Luffa cylindrica (L.) Roem promotes branched-chain amino acid catabolism in the circulation system via gut microbiota in diet-induced obese mice. Food Chem. 2020;320:126648. doi: 10.1016/j.foodchem.2020.126648. PubMed DOI

Chen H., Nie Q., Hu J., Huang X., Yin J., Nie S. Multiomics Approach to Explore the Amelioration Mechanisms of Glucomannans on the Metabolic Disorder of Type 2 Diabetic Rats. J. Agric. Food Chem. 2021;69:2632–2645. doi: 10.1021/acs.jafc.0c07871. PubMed DOI

Ridaura V.K., Faith J.J., Rey F.E., Cheng J., Duncan A.E., Kau A.L., Griffin N.W., Lombard V., Henrissat B., Bain J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341:1241214. doi: 10.1126/science.1241214. PubMed DOI PMC

Yue S.J., Liu J., Wang A.T., Meng X.T., Yang Z.R., Peng C., Guan H.S., Wang C.Y., Yan D. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. Am. J. Physiol. Endocrinol. Metab. 2019;316:E73–E85. doi: 10.1152/ajpendo.00256.2018. PubMed DOI

Wu W., Zhang L., Xia B., Tang S., Liu L., Xie J., Zhang H. Bioregional Alterations in Gut Microbiome Contribute to the Plasma Metabolomic Changes in Pigs Fed with Inulin. Microorganisms. 2020;8:111. doi: 10.3390/microorganisms8010111. PubMed DOI PMC

Sun Y., He Z., Li J., Gong S., Yuan S., Li T., Ning N., Xing L., Zhang L., Chen F., et al. Gentamicin Induced Microbiome Adaptations Associate With Increased BCAA Levels and Enhance Severity of Influenza Infection. Front. Immunol. 2020;11:608895. doi: 10.3389/fimmu.2020.608895. PubMed DOI PMC

Effects of Lactiplantibacillus plantarum and Lacticaseibacillus paracasei supplementation on the faecal metabolome in children with coeliac disease autoimmunity: a randomised, double-blinded placebo-controlled clinical trial

Multi-omics signatures in new-onset diabetes predict metabolic response to dietary inulin: findings from an observational study followed by an interventional trial

Healthy microbiome - a mere idea or a sound concept?